Rising Pancreatic Adenocarcinoma and Type 2 Diabetes Mellitus-Related Mortality in the United States, 2000 to 2024, With Forecasts to 2034
Mortality from concurrent pancreatic adenocarcinoma and T2DM has risen, with marked disparities by sex, race, age, and region, and the projected increase underscores the need for targeted prevention and early detection in high-risk diabetic populations.
Authors
- Abdul Rafae Faisal (ORCID: https://orcid.org/0000-0003-0249-8327)
- Jyotirmoy Biswas (ORCID: https://orcid.org/0000-0001-9357-0448)
- Asad Zaman
- Rick Maity (ORCID: https://orcid.org/0009-0003-5316-2329)
- Muhammad U. Saeed
- Ali S. Hafeez
- Adnan Bhat
- Arkadeep Dhali
Institutions
- Indian Institute of Technology Kharagpur (IN)
- Government Medical College (IN)
- Nishtar Medical College and Hospital (PK)
- University of Florida (US)
- Medical Research Scotland (GB)
- Sheffield Teaching Hospitals NHS Foundation Trust (GB)
- The Queen's Medical Research Institute (GB)
- Imperial College London (GB)
- University of Sheffield (GB)
- University of Edinburgh (GB)
Publication Details
- Journal
- American Journal of Clinical Oncology
- Published
- 2026-03-02
- DOI
- https://doi.org/10.1097/coc.0000000000001310
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00